| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
83 |
| issn |
1743-4270
1743-4289 |
| issueIdentifier |
2 |
| pageRange |
82-83 |
| publicationName |
Nature clinical practice. Urology |
| startingPage |
82 |
| bibliographicCitation |
Atzpodien J. Does addition of 13-cis-retinoic acid to interferon-alpha2a improve survival in patients with metastatic RCC? Nat Clin Pract Urol. 2006 Feb;3(2):82–3. doi: 10.1038/ncpuro0410. PMID: 16470206. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51c221efc6fab11f1cf0f119e718a3be |
| date |
200602 |
| identifier |
https://doi.org/10.1038/ncpuro0410
https://pubmed.ncbi.nlm.nih.gov/16470206 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1743-4270
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32709
https://portal.issn.org/resource/ISSN/1743-4289 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Does addition of 13-cis-retinoic acid to interferon-alpha2a improve survival in patients with metastatic RCC? |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282379
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_78dae9a89b54166488497136181a461a
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7d6a1edc08997e3d7b61d7a07051efb5 |